Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 11, 2023Cell DiscoveryOpen Access

High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYufeng LuoSLShuo LiuJXJiguo Xue

Discussion

Loading...

Member takes

Overview

In vitro high-throughput screening reveals key spike mutations enhancing infectivity and antibody resistance, highlighting mechanisms driving SARS-CoV-2 immune evasion.

Key Points

  • To systematically profile how extensive mutations across the SARS-CoV-2 spike glycoprotein alter ACE2 receptor affinity and evade neutralization by monoclonal antibodies.
  • Generated a lentiviral spike variant library in a mammalian cell-surface-display system using in silico chip synthesis and site-directed saturation mutagenesis.
  • Enriched and isolated variant candidates via single-cell fluorescence-activated sorting.
  • Identified and quantified mutational effects using third-generation DNA sequencing technologies.
  • Spike mutations S205F, Y453F, Q493A, Q493M, Q498H, Q498Y, N501F, and N501T demonstrated a 3- to 12-fold increase in viral infectivity.
  • Variants Y453F, Q493A, and Q498Y exhibited at least a 10-fold resistance to monoclonal antibodies REGN10933, LY-CoV555, and REGN10987, respectively.

Cite This Study

Luo et al. (2023) studied this question.

synapsesocial.com/papers/6a8a6bad9be9d02581bdad3dhttps://doi.org/10.1038/s41421-023-00534-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway2022 · 735 citations
  2. 2A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-22022 · 131 citations
  3. 3Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-22020 · 806 citations
  4. 4Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses2022 · 19 citations